Structure Therapeutics is trading at $25.22, down 5.47%, with broader risk-off sentiment a possible backdrop.
- No fresh company-specific announcement or catalyst surfaced in the October 8 search; the latest listed company clinical update was September 8.
- Shares fell in each of the six prior sessions, from $32.69 on September 29 to $26.68 on October 7.
- U.S. futures and major indexes were lower, while rising bond yields and elevated oil weighed on global markets; premarket volume/activity details were unavailable.